Patent · US Active

Cosmetic and pharmaceutical compositions comprising compounds that display retinoid like activities

US7803966B2 · kind B2 · utility

1Cited by

1References

11Claims

0Family size

Assignee

Johnson & Johnson Consumer France SAS · FR

Inventors

Thierry Oddos · Meudon, FR
Otto von Stetten · Aachen, DE
Luc Van Hijfte · Saint-Étienne-du-Rouvray, FR

Key dates

Filing date	Dec 16, 2008
Grant date	Sep 28, 2010
Priority date	—
Expiry date	Dec 22, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C245/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to novel compounds that display retinoid like activities, including HB-EGF (Heparin Binding Epidermal Growth Factor) release from keratinocytes, cell proliferation, and epidermal thickening without the irritation potentials, such as release of interleukin 8 and inhibition of terminal differentiation of keratinocytes. This invention also relates to the use of such a compound for both external and non-external applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.